Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Calin Lungu"'
Autor:
Marco Sardella, Glyn Belcher, Calin Lungu, Terenzio Ignoni, Manuela Camisa, Doris Irene Stenver, Paolo Porcelli, Margherita D’Antuono, Nicola Gian Castiglione, Anna Adams, Giovanni Furlan, Ilaria Grisoni, Sarah Hall, Laura Boga, Valentina Mancini, Mircea Ciuca, David Chonzi, Brian Edwards, Arduino A Mangoni, Marco Tuccori, Elena Prokofyeva, Fabio De Gregorio, Mario Bertazzoli Grabinski Broglio, Bert van Leeuwen, Paola Kruger, Christian Rausch, Hervé Le Louet
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
The collection and assessment of individual case safety reports (ICSRs) is important to detect unknown adverse drug reactions particularly in the first decade after approval of new chemical entities. However, regulations require that these activities
Externí odkaz:
https://doaj.org/article/e2f577c0d23646f1bd9f7bce36bd7551
Autor:
Marco Sardella, Calin Lungu
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 10 (2019)
Different strategies have been studied to allow a better characterization of the safety profile of orphan drugs soon after their approval. At the end of the development phases only few data are available because of the small number of subjects expose
Externí odkaz:
https://doaj.org/article/2f5c0c67c61c43cead79853498bd2704
Autor:
Fabio De Gregorio, Arduino A. Mangoni, Giovanni Furlan, Terenzio Ignoni, Marco Tuccori, Hervé Le Louet, Bert van Leeuwen, Nicola Gian Castiglione, Manuela Camisa, Marco Sardella, Anna L. Adams, Paolo Porcelli, Doris Irene Stenver, Glyn Belcher, Elena Prokofyeva, Valentina Mancini, Brian Edwards, Ilaria Grisoni, Mircea Ciuca, Mario Bertazzoli Grabinski Broglio, Margherita D'Antuono, David Chonzi, Laura Boga, Calin Lungu, Christian Rausch, Paola Kruger, Sarah Hall
Publikováno v:
Therapeutic Advances in Drug Safety, Vol 12 (2021)
Therapeutic Advances in Drug Safety
Therapeutic Advances in Drug Safety
The collection and assessment of individual case safety reports (ICSRs) is important to detect unknown adverse drug reactions particularly in the first decade after approval of new chemical entities. However, regulations require that these activities
Autor:
Michal Pirozynski, Amy Tanti, George Aislaitner, Dimitrios Kouvelas, John Joseph Borg, Calin Lungu, Anthony Serracino-Inglott
Publikováno v:
Therapeutic Advances in Drug Safety. 6:120-140
European Directives and Regulations introduced between late 2010 and 2012 have substantially overhauled pharmacovigilance processes across the European Union (EU). In this review, the implementation of the pharmacovigilance legislative framework by E
Autor:
Calin Lungu, Réjean Couture, Lingyun Wu, Denis deBlois, Adil El Midaoui, Caroline Robillard, Hui Wang
Publikováno v:
Canadian journal of physiology and pharmacology. 89(10)
This study sought to determine the impact of α-lipoic acid (LA) on superoxide anion (O2•–) production and peroxisome proliferator-activated receptor-α (PPARα) expression in liver tissue, plasma free fatty acids (FFA), and aortic remodeling in